vs
Side-by-side financial comparison of MID PENN BANCORP INC (MPB) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $62.0M, roughly 1.2× MID PENN BANCORP INC). On growth, MID PENN BANCORP INC posted the faster year-over-year revenue change (30.8% vs 27.7%). MID PENN BANCORP INC produced more free cash flow last quarter ($71.8M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 21.1%).
Commerce Bancorp was a Cherry Hill, New Jersey–based bank created in 1973. In 2007, it was purchased by Toronto-Dominion Bank, which merged Commerce into TD Banknorth, the latter of which was rebranded to TD Bank.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
MPB vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.0M | $75.5M |
| Net Profit | $19.4M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 43.6% | 22.7% |
| Net Margin | 31.4% | — |
| Revenue YoY | 30.8% | 27.7% |
| Net Profit YoY | 47.0% | — |
| EPS (diluted) | $0.83 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.0M | $75.5M | ||
| Q3 25 | $61.8M | $54.5M | ||
| Q2 25 | $54.3M | $52.4M | ||
| Q1 25 | $47.7M | $46.0M | ||
| Q4 24 | $47.4M | $59.1M | ||
| Q3 24 | $45.3M | $80.5M | ||
| Q2 24 | $44.1M | $47.1M | ||
| Q1 24 | $42.3M | $43.8M |
| Q4 25 | $19.4M | — | ||
| Q3 25 | $18.3M | $8.8M | ||
| Q2 25 | $4.8M | $5.9M | ||
| Q1 25 | $13.7M | $3.0M | ||
| Q4 24 | $13.2M | — | ||
| Q3 24 | $12.3M | $20.3M | ||
| Q2 24 | $11.8M | $-4.5M | ||
| Q1 24 | $12.1M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | 43.6% | 22.7% | ||
| Q3 25 | 39.3% | 17.6% | ||
| Q2 25 | 7.9% | 12.7% | ||
| Q1 25 | 35.2% | 8.7% | ||
| Q4 24 | 34.1% | 22.6% | ||
| Q3 24 | 32.8% | 27.4% | ||
| Q2 24 | 32.4% | -4.6% | ||
| Q1 24 | 34.8% | -5.3% |
| Q4 25 | 31.4% | — | ||
| Q3 25 | 29.6% | 16.2% | ||
| Q2 25 | 8.8% | 11.2% | ||
| Q1 25 | 28.8% | 6.5% | ||
| Q4 24 | 27.9% | — | ||
| Q3 24 | 27.1% | 25.2% | ||
| Q2 24 | 26.7% | -9.6% | ||
| Q1 24 | 28.7% | -11.0% |
| Q4 25 | $0.83 | $0.26 | ||
| Q3 25 | $0.79 | $0.17 | ||
| Q2 25 | $0.22 | $0.12 | ||
| Q1 25 | $0.71 | $0.06 | ||
| Q4 24 | $0.72 | $0.40 | ||
| Q3 24 | $0.74 | $0.41 | ||
| Q2 24 | $0.71 | $-0.09 | ||
| Q1 24 | $0.73 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $814.1M | $130.3M |
| Total Assets | $6.1B | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $814.1M | $130.3M | ||
| Q3 25 | $796.3M | $115.3M | ||
| Q2 25 | $775.7M | $104.7M | ||
| Q1 25 | $667.9M | $97.1M | ||
| Q4 24 | $655.0M | $92.1M | ||
| Q3 24 | $573.1M | $71.1M | ||
| Q2 24 | $559.7M | $48.5M | ||
| Q1 24 | $551.0M | $51.0M |
| Q4 25 | $6.1B | $216.3M | ||
| Q3 25 | $6.3B | $202.9M | ||
| Q2 25 | $6.4B | $194.9M | ||
| Q1 25 | $5.5B | $196.2M | ||
| Q4 24 | $5.5B | $213.3M | ||
| Q3 24 | $5.5B | $220.7M | ||
| Q2 24 | $5.4B | $205.0M | ||
| Q1 24 | $5.3B | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $80.0M | $14.4M |
| Free Cash FlowOCF − Capex | $71.8M | $14.4M |
| FCF MarginFCF / Revenue | 115.8% | 19.1% |
| Capex IntensityCapex / Revenue | 13.3% | 0.0% |
| Cash ConversionOCF / Net Profit | 4.12× | — |
| TTM Free Cash FlowTrailing 4 quarters | $132.1M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.0M | $14.4M | ||
| Q3 25 | $26.3M | $9.7M | ||
| Q2 25 | $29.0M | $14.1M | ||
| Q1 25 | $11.5M | $3.6M | ||
| Q4 24 | $51.4M | $15.6M | ||
| Q3 24 | $16.9M | $11.0M | ||
| Q2 24 | $18.0M | $1.0M | ||
| Q1 24 | $12.4M | $11.2M |
| Q4 25 | $71.8M | $14.4M | ||
| Q3 25 | $24.3M | $9.7M | ||
| Q2 25 | $27.2M | $14.1M | ||
| Q1 25 | $8.8M | $3.6M | ||
| Q4 24 | $44.5M | $15.6M | ||
| Q3 24 | $16.8M | $11.0M | ||
| Q2 24 | $17.7M | $1.0M | ||
| Q1 24 | $12.1M | — |
| Q4 25 | 115.8% | 19.1% | ||
| Q3 25 | 39.4% | 17.7% | ||
| Q2 25 | 50.1% | 26.8% | ||
| Q1 25 | 18.4% | 7.7% | ||
| Q4 24 | 93.8% | 26.4% | ||
| Q3 24 | 37.1% | 13.7% | ||
| Q2 24 | 40.2% | 2.1% | ||
| Q1 24 | 28.5% | — |
| Q4 25 | 13.3% | 0.0% | ||
| Q3 25 | 3.1% | 0.0% | ||
| Q2 25 | 3.2% | 0.0% | ||
| Q1 25 | 5.7% | 0.1% | ||
| Q4 24 | 14.6% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.7% | 0.0% | ||
| Q1 24 | 0.8% | 0.0% |
| Q4 25 | 4.12× | — | ||
| Q3 25 | 1.44× | 1.10× | ||
| Q2 25 | 6.08× | 2.41× | ||
| Q1 25 | 0.84× | 1.21× | ||
| Q4 24 | 3.88× | — | ||
| Q3 24 | 1.37× | 0.54× | ||
| Q2 24 | 1.53× | — | ||
| Q1 24 | 1.02× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
